Correlation Between Living Cell and Sino Biopharmaceutica

Can any of the company-specific risk be diversified away by investing in both Living Cell and Sino Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Living Cell and Sino Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Living Cell Technologies and Sino Biopharmaceutical Ltd, you can compare the effects of market volatilities on Living Cell and Sino Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Living Cell with a short position of Sino Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Living Cell and Sino Biopharmaceutica.

Diversification Opportunities for Living Cell and Sino Biopharmaceutica

-0.58

Correlation Coefficient

Living Cell  Sino Biopharmaceutica

Excellent diversification

The 3 months correlation between Living and Sino is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Living Cell Technologies and Sino Biopharmaceutical Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sino Biopharmaceutical and Living Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Living Cell Technologies are associated (or correlated) with Sino Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sino Biopharmaceutical has no effect on the direction of Living Cell i.e., Living Cell and Sino Biopharmaceutica go up and down completely randomly.

Pair Corralation between Living Cell and Sino Biopharmaceutica

Assuming the 90 days horizon Living Cell Technologies is expected to under-perform the Sino Biopharmaceutica. In addition to that, Living Cell is 3.4 times more volatile than Sino Biopharmaceutical Ltd. It trades about -0.04 of its total potential returns per unit of risk. Sino Biopharmaceutical Ltd is currently generating about 0.08 per unit of volatility. If you would invest  800.00  in Sino Biopharmaceutical Ltd on September 12, 2024 and sell it today you would earn a total of  105.00  from holding Sino Biopharmaceutical Ltd or generate 13.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Living Cell Technologies  vs.  Sino Biopharmaceutical Ltd

Living Cell Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Living Cell Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Sino Biopharmaceutical

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Sino Biopharmaceutical Ltd are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain primary indicators, Sino Biopharmaceutica showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Living Cell and Sino Biopharmaceutica

The main advantage of trading using opposite Living Cell and Sino Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Living Cell position performs unexpectedly, Sino Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sino Biopharmaceutica will offset losses from the drop in Sino Biopharmaceutica's long position.

The idea behind Living Cell Technologies and Sino Biopharmaceutical Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.